Immunomodulatory Effects of BRAF, MEK, and CDK4/6 Inhibitors: Implications for Combining Targeted Therapy and Immune Checkpoint Blockade for the Treatment of Melanoma

by Emily J. Lelliott, Emily J. Lelliott, Grant A. McArthur, Grant A. McArthur, Jane Oliaro, Jane Oliaro, Jane Oliaro, Karen E. Sheppard, Karen E. Sheppard, Karen E. Sheppard
Published 2021-05-01

Obesity and the Impact on Cutaneous Melanoma: Friend or Foe?

by Lorey K. Smith, Shaghayegh Arabi, Emily J. Lelliott, Grant A. McArthur, Karen E. Sheppard
Published 2020-06-01